Bessemer Group Inc. Has $443,000 Position in Teleflex Incorporated $TFX

Bessemer Group Inc. reduced its stake in Teleflex Incorporated (NYSE:TFX) by 32.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,740 shares of the medical technology company’s stock after selling 1,771 shares during the period. Bessemer Group Inc.’s holdings in Teleflex were worth $443,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Thurston Springer Miller Herd & Titak Inc. boosted its stake in shares of Teleflex by 242.9% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 153 shares in the last quarter. Banque Cantonale Vaudoise bought a new position in Teleflex in the 1st quarter valued at approximately $27,000. Costello Asset Management INC bought a new position in Teleflex in the 1st quarter valued at approximately $28,000. Brooklyn Investment Group raised its holdings in Teleflex by 258.6% in the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock valued at $29,000 after buying an additional 150 shares during the last quarter. Finally, Allworth Financial LP raised its holdings in Teleflex by 504.8% in the 1st quarter. Allworth Financial LP now owns 254 shares of the medical technology company’s stock valued at $34,000 after buying an additional 212 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Stock Performance

NYSE:TFX opened at $124.25 on Monday. The company has a fifty day moving average of $126.61 and a 200-day moving average of $123.44. The firm has a market capitalization of $5.49 billion, a P/E ratio of 29.24, a P/E/G ratio of 1.79 and a beta of 1.05. The company has a quick ratio of 1.44, a current ratio of 2.41 and a debt-to-equity ratio of 0.42. Teleflex Incorporated has a twelve month low of $108.90 and a twelve month high of $215.13.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, beating the consensus estimate of $3.36 by $0.37. The company had revenue of $780.90 million during the quarter, compared to analyst estimates of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. Teleflex’s revenue for the quarter was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.42 EPS. As a group, sell-side analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Analyst Ratings Changes

TFX has been the subject of a number of research reports. Zacks Research lowered shares of Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. Mizuho raised their price objective on shares of Teleflex from $130.00 to $135.00 and gave the company a “neutral” rating in a report on Friday, August 1st. Weiss Ratings reiterated a “sell (d+)” rating on shares of Teleflex in a report on Wednesday, October 8th. Royal Bank Of Canada raised their price objective on shares of Teleflex from $130.00 to $135.00 and gave the company a “sector perform” rating in a report on Friday, August 1st. Finally, Wall Street Zen lowered shares of Teleflex from a “strong-buy” rating to a “buy” rating in a report on Monday, September 15th. One research analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Reduce” and an average price target of $141.57.

Insider Buying and Selling at Teleflex

In other Teleflex news, CEO Liam Kelly purchased 1,500 shares of the firm’s stock in a transaction on Tuesday, August 5th. The stock was acquired at an average price of $115.07 per share, for a total transaction of $172,605.00. Following the purchase, the chief executive officer owned 45,267 shares of the company’s stock, valued at $5,208,873.69. This trade represents a 3.43% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Jaewon Ryu purchased 1,500 shares of the firm’s stock in a transaction on Tuesday, August 5th. The shares were acquired at an average price of $115.00 per share, with a total value of $172,500.00. Following the purchase, the director directly owned 3,727 shares in the company, valued at $428,605. This represents a 67.36% increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased a total of 5,500 shares of company stock worth $633,590 in the last ninety days. 1.40% of the stock is currently owned by corporate insiders.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.